DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats

The results of the present study have demonstrated that DA-8159 reverses the decrease in ICP induced by SSRI treatment, suggesting that DA-8159 may be a potential therapeutic agent for the treatment of erectile dysfunction associated with the use of SSRIs.